Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Leukemia & Lymphoma

Font Size

New Leukemia Vaccine May Prolong Life

Experimental Leukemia Treatment Boosts Immune System
WebMD Health News
Reviewed by Louise Chang, MD

Dec. 10, 2007 -- An experimental new leukemia treatment that boosts the body's own immune system to fight disease may prolong life.

Early clinical trials show some people who responded to the vaccine experienced event-free survival that was three times longer than those who didn't respond to the leukemia treatment.

But researchers are quick to point out that this is not a leukemia cure, as only about half of the people with active leukemia in the study experienced an immune response to the vaccine. Even so, researchers were impressed by these early results and plan further clinical trials to evaluate the effectiveness of this new approach to leukemia treatment.

"We did not expect dramatic responses in this clinical trial, and were pleasantly surprised to see the clinical responses and improved event-free survival," says researcher Muzaffar Qazilbash, MD, in a news release. Qazilbash is associate professor in the department of stem cell transplantation and cellular therapy at the University of Texas M.D. Anderson Cancer Center.

The results of the study were presented this week at the American Society of Hematology conference.

New Approach in Leukemia Treatment

The phase I/II clinical trial evaluated the effect and safety of the leukemia vaccine in 66 people with acute myeloid leukemia over three years of follow-up. Of the 53 patients with active leukemia, 25 (47%) had an immune response to the treatment (as determined by lab tests) and 28 did not.

Those that had an immune response experienced a longer period of event-free survival from their disease during the study, an average of 8.7 months compared with 2.4 months among those who didn't respond to the vaccine.

The leukemia vaccine is derived from two leukemia-associated antigens and works by stimulating the immune system to selectively kill leukemia cells.

"Immunotherapy works best for low level of disease," says Qazilbash. "So patients with low leukemia burden may get the maximum benefit."

Today on WebMD

stem cells
What are they and why do we need them?
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Do you know the symptoms?
Vitamin D
New Treatments For Non-Hodgkins Lymphoma
Lifestyle Tips for Depression Slideshow
Pets Improve Your Health